loratadine has been researched along with Basophilic Leukemia, Acute in 1 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berthon, B | 1 |
Taudou, G | 1 |
Combettes, L | 1 |
Czarléwski, W | 1 |
Carmi-Leroy, A | 1 |
Marchand, F | 1 |
Weyer, A | 1 |
1 other study available for loratadine and Basophilic Leukemia, Acute
Article | Year |
---|---|
In vitro inhibition, by loratadine and descarboxyethoxyloratadine, of histamine release from human basophils, and of histamine release and intracellular calcium fluxes in rat basophilic leukemia cells (RBL-2H3).
Topics: Animals; Antibodies, Anti-Idiotypic; Basophils; Calcium; Cytosol; Dinitrobenzenes; Dinitrophenols; H | 1994 |